Patients with DM and DM+HT, as compared to dialysis patients without DM, presented several significant risk changes, namely, higher BMI scores, as well as higher values of TG, oxLDL, oxLDL/LDLc, and leptin, and lower HDLc, large HDL subfraction, and adiponectin. The gene discussed is LEP; the disease is hematocrit.